2008The Nurse PractitionerRequires access

Rotigotine transdermal system (Neupro)

Gary Laustsen, Muriel Shaul, Gwendolyn Short

Open publisher page 3 citations

Abstract

In Brief In 2007, the FDA approved several new drugs for use in primary care. From new antibiotics to innovative contraception methods, nurse practitioners need to be aware of the latest medications now available.

About this research paper

What this paper is about

In Brief In 2007, the FDA approved several new drugs for use in primary care. From new antibiotics to innovative contraception methods, nurse practitioners need to be aware of the latest medications now available.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In Brief In 2007, the FDA approved several new drugs for use in primary care. From new antibiotics to innovative contraception methods, nurse practitioners need to be aware of the latest medications now available.

Key concepts: Rotigotine, Transdermal, Medicine, Pharmacology, Internal medicine, Disease, Parkinson's disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Rotigotine transdermal system (Neupro) — Research Paper | ScholarLens